FST has a high affinity for activin A [18], and increasing evidence reveals that dysregulation of the FST/activin A system could lead to alterations of the normal homeostasis of prostate tissue and cause development and progression of prostate cancer [43, 44, 45, 46]. The gene discussed is FST; the disease is prostate carcinoma.